-
1.
公开(公告)号:WO2008129129A1
公开(公告)日:2008-10-30
申请号:PCT/FI2008/050205
申请日:2008-04-18
申请人: KUOPION YLIOPISTO , MYLLYMÄKI, Mikko , CASTILLO-MELENDEZ, Joel , KOSKINEN, Ari , MINKKILÄ, Anna , SAARIO, Susanna , NEVALAINEN, Tapio , JÄRVINEN, Tapio , POSO, Antti , SALO-AHEN, Outi
发明人: MYLLYMÄKI, Mikko , CASTILLO-MELENDEZ, Joel , KOSKINEN, Ari , MINKKILÄ, Anna , SAARIO, Susanna , NEVALAINEN, Tapio , JÄRVINEN, Tapio , POSO, Antti , SALO-AHEN, Outi
IPC分类号: C07C271/44 , C07C271/56 , C07D213/79 , C07D233/90 , C07D257/04 , C07D263/14 , C07D263/16 , C07D263/32 , C07D263/56 , C07D271/06 , C07D277/24 , C07D277/64 , C07D285/06 , A61K31/325 , A61K31/41 , A61P3/00 , A61P9/00 , A61P25/00 , A61P27/06 , A61P29/00
CPC分类号: C07C271/56 , C07C2601/08 , C07C2601/14 , C07D213/79 , C07D233/22 , C07D233/90 , C07D257/04 , C07D263/14 , C07D263/16 , C07D263/32 , C07D263/56 , C07D271/06 , C07D277/24 , C07D277/64 , C07D285/06 , C07D413/06
摘要: Fatty acid amide hydrolase inhibitors of the Formula (I) are provided, wherein R is a heterocyclic or heterocyclic carbonyl moiety and R' is a group consisting of H, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl. Pharmaceutical compositions and methods comprising compounds of Formula (I) may be used for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity. Thus, the compounds may be administered to treat, anxiety, epilepsy, depression, pain, inflammation, appetite disorders, glaucoma and insomnia.
摘要翻译: 提供式(I)的脂肪酸酰胺水解酶抑制剂,其中R是杂环或杂环羰基部分,R'是由H,取代或未取代的烷基,取代或未取代的杂烷基,取代或未取代的芳基和取代的 或未取代的杂芳基。 包含式(I)化合物的药物组合物和方法可用于治疗由脂肪酰胺水解酶(FAAH)活性介导的疾病状态,病症和病况。 因此,可以施用化合物以治疗,焦虑,癫痫,抑郁,疼痛,炎症,食欲障碍,青光眼和失眠。